Modulation of lipolysis and glycolysis pathways in cancer stem cells changed multipotentiality and differentiation capacity toward endothelial lineage

Cancer stem cells obtain energy demand through the activation of glycolysis and lipolysis. It seems that the use of approached targeting glycolysis and lipolysis could be an effective strategy for the inhibition of cancer stem cells. In the current experiment, we studied the potential effect of glyc...

Full description

Saved in:
Bibliographic Details
Published inCell & bioscience Vol. 9; no. 1; p. 30
Main Authors Pouyafar, Ayda, Heydarabad, Milad Zadi, Abdolalizadeh, Jalal, Zade, Jalal Abdolali, Rahbarghazi, Reza, Talebi, Mehdi
Format Journal Article
LanguageEnglish
Published England BioMed Central Ltd 27.03.2019
BioMed Central
BMC
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Cancer stem cells obtain energy demand through the activation of glycolysis and lipolysis. It seems that the use of approached targeting glycolysis and lipolysis could be an effective strategy for the inhibition of cancer stem cells. In the current experiment, we studied the potential effect of glycolysis and lipolysis inhibition on cancer stem cells differentiation and mesenchymal-epithelial-transition capacity. Cancer stem cells were enriched from human ovarian cells namely SKOV3 by using MACS technique. Cells were exposed to Lonidamine, an inhibitor of glycolysis, and TOFA, a potent inhibitor of lipolysis for 7 days in endothelial differentiation medium; EGM-2 and cell viability was studied by MTT assay. At the respective time point, the transcription level of genes participating in EMT such as -1, -2, , -1, -2 and - were measured by real-time PCR analysis. Our data noted that the inhibition of lipolysis and glycolysis could decrease cell viability compared to the control of cancer stem cells. The inhibition of glycolysis prohibited the expression of -1, , and while increased endothelial differentiation rate indicated by the expression of - . In contrast, the inhibition of lipolysis increased EMT associated genes and reduced endothelial differentiation rate by suppressing the transcription of - . Notably, the simultaneous inhibition of glycolysis and lipolysis had moderate effects on the transcription of EMT genes. We concluded that the modulation of the metabolic pathway of glycolysis in ovarian CSCs is more effective than the inhibition of lipolysis in the control of angiogenesis potential and stemness feature.
AbstractList Abstract Cancer stem cells obtain energy demand through the activation of glycolysis and lipolysis. It seems that the use of approached targeting glycolysis and lipolysis could be an effective strategy for the inhibition of cancer stem cells. In the current experiment, we studied the potential effect of glycolysis and lipolysis inhibition on cancer stem cells differentiation and mesenchymal–epithelial-transition capacity. Cancer stem cells were enriched from human ovarian cells namely SKOV3 by using MACS technique. Cells were exposed to Lonidamine, an inhibitor of glycolysis, and TOFA, a potent inhibitor of lipolysis for 7 days in endothelial differentiation medium; EGM-2 and cell viability was studied by MTT assay. At the respective time point, the transcription level of genes participating in EMT such as Zeb-1, -2, Vimentin, Snail-1, -2 and VE-cadherin were measured by real-time PCR analysis. Our data noted that the inhibition of lipolysis and glycolysis could decrease cell viability compared to the control of cancer stem cells. The inhibition of glycolysis prohibited the expression of Zeb-1, Snails, and Vimentin while increased endothelial differentiation rate indicated by the expression of VE-cadherin. In contrast, the inhibition of lipolysis increased EMT associated genes and reduced endothelial differentiation rate by suppressing the transcription of VE-cadherin. Notably, the simultaneous inhibition of glycolysis and lipolysis had moderate effects on the transcription of EMT genes. We concluded that the modulation of the metabolic pathway of glycolysis in ovarian CSCs is more effective than the inhibition of lipolysis in the control of angiogenesis potential and stemness feature.
Cancer stem cells obtain energy demand through the activation of glycolysis and lipolysis. It seems that the use of approached targeting glycolysis and lipolysis could be an effective strategy for the inhibition of cancer stem cells. In the current experiment, we studied the potential effect of glycolysis and lipolysis inhibition on cancer stem cells differentiation and mesenchymal–epithelial-transition capacity. Cancer stem cells were enriched from human ovarian cells namely SKOV3 by using MACS technique. Cells were exposed to Lonidamine, an inhibitor of glycolysis, and TOFA, a potent inhibitor of lipolysis for 7 days in endothelial differentiation medium; EGM-2 and cell viability was studied by MTT assay. At the respective time point, the transcription level of genes participating in EMT such as Zeb-1, -2, Vimentin, Snail-1, -2 and VE-cadherin were measured by real-time PCR analysis. Our data noted that the inhibition of lipolysis and glycolysis could decrease cell viability compared to the control of cancer stem cells. The inhibition of glycolysis prohibited the expression of Zeb-1, Snails, and Vimentin while increased endothelial differentiation rate indicated by the expression of VE-cadherin. In contrast, the inhibition of lipolysis increased EMT associated genes and reduced endothelial differentiation rate by suppressing the transcription of VE-cadherin. Notably, the simultaneous inhibition of glycolysis and lipolysis had moderate effects on the transcription of EMT genes. We concluded that the modulation of the metabolic pathway of glycolysis in ovarian CSCs is more effective than the inhibition of lipolysis in the control of angiogenesis potential and stemness feature.
Cancer stem cells obtain energy demand through the activation of glycolysis and lipolysis. It seems that the use of approached targeting glycolysis and lipolysis could be an effective strategy for the inhibition of cancer stem cells. In the current experiment, we studied the potential effect of glycolysis and lipolysis inhibition on cancer stem cells differentiation and mesenchymal–epithelial-transition capacity. Cancer stem cells were enriched from human ovarian cells namely SKOV3 by using MACS technique. Cells were exposed to Lonidamine, an inhibitor of glycolysis, and TOFA, a potent inhibitor of lipolysis for 7 days in endothelial differentiation medium; EGM-2 and cell viability was studied by MTT assay. At the respective time point, the transcription level of genes participating in EMT such as Zeb -1, -2, Vimentin , Snail -1, -2 and VE - cadherin were measured by real-time PCR analysis. Our data noted that the inhibition of lipolysis and glycolysis could decrease cell viability compared to the control of cancer stem cells. The inhibition of glycolysis prohibited the expression of Zeb -1, Snails , and Vimentin while increased endothelial differentiation rate indicated by the expression of VE - cadherin . In contrast, the inhibition of lipolysis increased EMT associated genes and reduced endothelial differentiation rate by suppressing the transcription of VE - cadherin . Notably, the simultaneous inhibition of glycolysis and lipolysis had moderate effects on the transcription of EMT genes. We concluded that the modulation of the metabolic pathway of glycolysis in ovarian CSCs is more effective than the inhibition of lipolysis in the control of angiogenesis potential and stemness feature.
Cancer stem cells obtain energy demand through the activation of glycolysis and lipolysis. It seems that the use of approached targeting glycolysis and lipolysis could be an effective strategy for the inhibition of cancer stem cells. In the current experiment, we studied the potential effect of glycolysis and lipolysis inhibition on cancer stem cells differentiation and mesenchymal-epithelial-transition capacity. Cancer stem cells were enriched from human ovarian cells namely SKOV3 by using MACS technique. Cells were exposed to Lonidamine, an inhibitor of glycolysis, and TOFA, a potent inhibitor of lipolysis for 7 days in endothelial differentiation medium; EGM-2 and cell viability was studied by MTT assay. At the respective time point, the transcription level of genes participating in EMT such as -1, -2, , -1, -2 and - were measured by real-time PCR analysis. Our data noted that the inhibition of lipolysis and glycolysis could decrease cell viability compared to the control of cancer stem cells. The inhibition of glycolysis prohibited the expression of -1, , and while increased endothelial differentiation rate indicated by the expression of - . In contrast, the inhibition of lipolysis increased EMT associated genes and reduced endothelial differentiation rate by suppressing the transcription of - . Notably, the simultaneous inhibition of glycolysis and lipolysis had moderate effects on the transcription of EMT genes. We concluded that the modulation of the metabolic pathway of glycolysis in ovarian CSCs is more effective than the inhibition of lipolysis in the control of angiogenesis potential and stemness feature.
Cancer stem cells obtain energy demand through the activation of glycolysis and lipolysis. It seems that the use of approached targeting glycolysis and lipolysis could be an effective strategy for the inhibition of cancer stem cells. In the current experiment, we studied the potential effect of glycolysis and lipolysis inhibition on cancer stem cells differentiation and mesenchymal-epithelial-transition capacity. Cancer stem cells were enriched from human ovarian cells namely SKOV3 by using MACS technique. Cells were exposed to Lonidamine, an inhibitor of glycolysis, and TOFA, a potent inhibitor of lipolysis for 7 days in endothelial differentiation medium; EGM-2 and cell viability was studied by MTT assay. At the respective time point, the transcription level of genes participating in EMT such as Zeb-1, -2, Vimentin, Snail-1, -2 and VE-cadherin were measured by real-time PCR analysis. Our data noted that the inhibition of lipolysis and glycolysis could decrease cell viability compared to the control of cancer stem cells. The inhibition of glycolysis prohibited the expression of Zeb-1, Snails, and Vimentin while increased endothelial differentiation rate indicated by the expression of VE-cadherin. In contrast, the inhibition of lipolysis increased EMT associated genes and reduced endothelial differentiation rate by suppressing the transcription of VE-cadherin. Notably, the simultaneous inhibition of glycolysis and lipolysis had moderate effects on the transcription of EMT genes. We concluded that the modulation of the metabolic pathway of glycolysis in ovarian CSCs is more effective than the inhibition of lipolysis in the control of angiogenesis potential and stemness feature. Keywords: Glycolysis, Lipolysis, EMT, Ovarian cancer stem cells
ArticleNumber 30
Audience Academic
Author Abdolalizadeh, Jalal
Pouyafar, Ayda
Rahbarghazi, Reza
Zade, Jalal Abdolali
Talebi, Mehdi
Heydarabad, Milad Zadi
Author_xml – sequence: 1
  givenname: Ayda
  surname: Pouyafar
  fullname: Pouyafar, Ayda
  organization: 1Stem Cell Research Center, Tabriz University of Medical Sciences, Imam Reza St., Daneshgah St., Tabriz, 5166614756 Iran
– sequence: 2
  givenname: Milad Zadi
  surname: Heydarabad
  fullname: Heydarabad, Milad Zadi
  organization: 1Stem Cell Research Center, Tabriz University of Medical Sciences, Imam Reza St., Daneshgah St., Tabriz, 5166614756 Iran
– sequence: 3
  givenname: Jalal
  surname: Abdolalizadeh
  fullname: Abdolalizadeh, Jalal
– sequence: 4
  givenname: Jalal Abdolali
  surname: Zade
  fullname: Zade, Jalal Abdolali
  organization: 2Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
– sequence: 5
  givenname: Reza
  orcidid: 0000-0003-3864-9166
  surname: Rahbarghazi
  fullname: Rahbarghazi, Reza
  organization: 3Department of Applied Cell Sciences, Faculty of Advanced Medical Sciences, Tabriz University of Medical Sciences, Tabriz, Iran
– sequence: 6
  givenname: Mehdi
  surname: Talebi
  fullname: Talebi, Mehdi
  organization: 2Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
BackLink https://www.ncbi.nlm.nih.gov/pubmed/30962872$$D View this record in MEDLINE/PubMed
BookMark eNptUstu1TAUjFARLaUfwAZFYgOLFD_z2CBVFY8rFSFB95Zjn-S6SuxL7LTcfgjfy7kPSi8iXiQZz4w9R_M8O_LBQ5a9pOSc0rp8FymXVV0Q2hSENby4f5KdMCJkwStCjx59H2dnMd4QfERDSSWfZcecNCWrK3aS_foS7Dzo5ILPQ5cPbhWGdXQx197m_bA2-9-VTss7vY6587nR3sCUxwRjbmAYYm6W2vdg83EeEjok8MnpwaX11sa6roNpi23PMXqlzWYzhTs92Ry8DWkJA0rwAh50Dy-yp50eIpzt36fZ9ccP15efi6uvnxaXF1eFkY1IRSuYFZYTK40wtaSGtFJCqSXUDZEtVLSVXLJSkpKXjCGrJRWArrTlAoCfZoudrQ36Rq0mN-pprYJ2aguEqVd6Ss4MoBrDm0ZCSyRnopayFZYQa7jpELVGo9f7nddqbkdEMO-khwPTwx3vlqoPt6oUvKolQ4M3e4Mp_JghJjW6uJmv9hDmqBgjmAFzEKS-_od6E-bJ46SQRamoORXsL6vXGMD5LuC5ZmOqLmRNeV1iFmSd_4eFy8LoDHauc4gfCN4eCJCT4Gfq9RyjWnz_dsilO66ZQowTdA_zoERtaqx2NVZYY7WpsbpHzavHg3xQ_Ckt_w0G0PGY
CitedBy_id crossref_primary_10_1016_j_lfs_2021_120041
crossref_primary_10_1186_s12935_021_01803_4
crossref_primary_10_1016_j_semcancer_2024_03_002
crossref_primary_10_3390_cells9092081
crossref_primary_10_1038_s41598_022_15660_2
crossref_primary_10_1016_j_biopha_2020_110623
crossref_primary_10_1186_s12967_020_02529_z
crossref_primary_10_18632_oncotarget_28241
crossref_primary_10_1186_s13578_019_0301_3
crossref_primary_10_3390_ijms22073775
crossref_primary_10_1016_j_advnut_2023_07_006
crossref_primary_10_1177_09636897211027524
crossref_primary_10_3389_fonc_2020_00499
crossref_primary_10_3389_fphar_2021_730751
crossref_primary_10_1186_s12906_021_03246_w
Cites_doi 10.1172/JCI39104
10.1517/14728222.2014.944899
10.1186/s13046-018-0784-5
10.1016/j.ccr.2013.02.021
10.1186/s12943-016-0555-x
10.1002/jcb.24671
10.1016/j.pharmthera.2013.01.014
10.1111/jcmm.13126
10.1038/s41598-017-02256-4
10.18632/oncotarget.2059
ContentType Journal Article
Copyright COPYRIGHT 2019 BioMed Central Ltd.
2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
The Author(s) 2019
Copyright_xml – notice: COPYRIGHT 2019 BioMed Central Ltd.
– notice: 2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: The Author(s) 2019
DBID NPM
AAYXX
CITATION
ISR
3V.
7X7
7XB
8FE
8FH
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BBNVY
BENPR
BHPHI
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
HCIFZ
K9.
LK8
M0S
M7P
PIMPY
PQEST
PQQKQ
PQUKI
PRINS
7X8
5PM
DOA
DOI 10.1186/s13578-019-0293-z
DatabaseName PubMed
CrossRef
Gale In Context: Science
ProQuest Central (Corporate)
ProQuest Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
ProQuest SciTech Collection
ProQuest Natural Science Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central
ProQuest Central Essentials
Biological Science Collection
AUTh Library subscriptions: ProQuest Central
ProQuest Natural Science Collection
ProQuest One Community College
ProQuest Central
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
SciTech Premium Collection (Proquest) (PQ_SDU_P3)
ProQuest Health & Medical Complete (Alumni)
Biological Sciences
Health & Medical Collection (Alumni Edition)
Biological Science Database
ProQuest - Publicly Available Content Database
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle PubMed
CrossRef
Publicly Available Content Database
ProQuest Central Student
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest Natural Science Collection
ProQuest Central China
ProQuest Central
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Natural Science Collection
ProQuest Central Korea
Biological Science Collection
ProQuest Biological Science Collection
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Biological Science Database
ProQuest SciTech Collection
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList
Publicly Available Content Database



PubMed

Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: BENPR
  name: AUTh Library subscriptions: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
EISSN 2045-3701
EndPage 30
ExternalDocumentID oai_doaj_org_article_9c3995eb05324855b4d00dc3cf95edca
A581386532
10_1186_s13578_019_0293_z
30962872
Genre Journal Article
Correspondence
GroupedDBID -A0
0R~
2VQ
3V.
53G
5VS
7X7
8FE
8FH
8FI
8FJ
AAFWJ
AAJSJ
ABDBF
ABUWG
ACGFS
ACRMQ
ADBBV
ADINQ
ADRAZ
ADUKV
AENEX
AFGXO
AFKRA
AFNRJ
AFPKN
AHBYD
AHSBF
AHYZX
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AOIJS
BAWUL
BBNVY
BCNDV
BENPR
BFQNJ
BHPHI
BMC
BPHCQ
BVXVI
C24
C6C
CCPQU
DIK
EBS
EJD
FYUFA
GROUPED_DOAJ
H13
HCIFZ
HMCUK
HYE
IAO
IGS
IHR
IPNFZ
ISR
ITC
KQ8
LK8
M48
M7P
M~E
NPM
O5R
O5S
OK1
PIMPY
PQQKQ
PROAC
RBZ
RIG
ROL
RPM
RSV
SBL
SOJ
TUS
UKHRP
AAYXX
ALIPV
CITATION
EBLON
PGMZT
ABVAZ
7XB
8FK
AZQEC
DWQXO
GNUQQ
K9.
PQEST
PQUKI
PRINS
7X8
5PM
ID FETCH-LOGICAL-c594t-b42d4d30d5c4c851c0b55e6a5e8905be71b5352650636225c4b07eea7ad34ee3
IEDL.DBID RPM
ISSN 2045-3701
IngestDate Thu Jul 04 21:06:13 EDT 2024
Tue Sep 17 20:44:21 EDT 2024
Fri Aug 16 01:14:21 EDT 2024
Fri Sep 13 01:04:34 EDT 2024
Thu Feb 22 23:55:50 EST 2024
Sat Dec 16 00:31:38 EST 2023
Thu Aug 01 19:59:56 EDT 2024
Thu Sep 12 19:25:00 EDT 2024
Thu May 23 23:46:06 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords Glycolysis
Ovarian cancer stem cells
EMT
Lipolysis
Language English
License Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c594t-b42d4d30d5c4c851c0b55e6a5e8905be71b5352650636225c4b07eea7ad34ee3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ORCID 0000-0003-3864-9166
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6437852/
PMID 30962872
PQID 2211483142
PQPubID 2040248
PageCount 1
ParticipantIDs doaj_primary_oai_doaj_org_article_9c3995eb05324855b4d00dc3cf95edca
pubmedcentral_primary_oai_pubmedcentral_nih_gov_6437852
proquest_miscellaneous_2206223620
proquest_journals_2211483142
gale_infotracmisc_A581386532
gale_infotracacademiconefile_A581386532
gale_incontextgauss_ISR_A581386532
crossref_primary_10_1186_s13578_019_0293_z
pubmed_primary_30962872
PublicationCentury 2000
PublicationDate 2019-03-27
PublicationDateYYYYMMDD 2019-03-27
PublicationDate_xml – month: 03
  year: 2019
  text: 2019-03-27
  day: 27
PublicationDecade 2010
PublicationPlace England
PublicationPlace_xml – name: England
– name: London
PublicationTitle Cell & bioscience
PublicationTitleAlternate Cell Biosci
PublicationYear 2019
Publisher BioMed Central Ltd
BioMed Central
BMC
Publisher_xml – name: BioMed Central Ltd
– name: BioMed Central
– name: BMC
References 31168353 - Cell Biosci. 2019 May 9;9:37
I Nakano (293_CR5) 2014
M Yi (293_CR8) 2018; 37
MS Schieber (293_CR10) 2013; 23
A Deshmukh (293_CR4) 2016; 15
A Deshmukh (293_CR1) 2017; 7
Y Shiozawa (293_CR2) 2013; 138
R Palorini (293_CR7) 2014; 115
H Zhao (293_CR9) 2017; 21
R Kalluri (293_CR3) 2009; 119
B Corominas-Faja (293_CR6) 2014; 5
References_xml – volume: 119
  start-page: 1420
  issue: 6
  year: 2009
  ident: 293_CR3
  publication-title: J Clin Investig
  doi: 10.1172/JCI39104
  contributor:
    fullname: R Kalluri
– volume-title: Therapeutic potential of targeting glucose metabolism in glioma stem cells
  year: 2014
  ident: 293_CR5
  doi: 10.1517/14728222.2014.944899
  contributor:
    fullname: I Nakano
– volume: 37
  start-page: 118
  issue: 1
  year: 2018
  ident: 293_CR8
  publication-title: J Exp Clin Cancer Res
  doi: 10.1186/s13046-018-0784-5
  contributor:
    fullname: M Yi
– volume: 23
  start-page: 265
  issue: 3
  year: 2013
  ident: 293_CR10
  publication-title: Cancer Cell
  doi: 10.1016/j.ccr.2013.02.021
  contributor:
    fullname: MS Schieber
– volume: 15
  start-page: 69
  issue: 1
  year: 2016
  ident: 293_CR4
  publication-title: Mol Cancer
  doi: 10.1186/s12943-016-0555-x
  contributor:
    fullname: A Deshmukh
– volume: 115
  start-page: 368
  issue: 2
  year: 2014
  ident: 293_CR7
  publication-title: J Cell Biochem
  doi: 10.1002/jcb.24671
  contributor:
    fullname: R Palorini
– volume: 138
  start-page: 285
  issue: 2
  year: 2013
  ident: 293_CR2
  publication-title: Pharmacol Ther
  doi: 10.1016/j.pharmthera.2013.01.014
  contributor:
    fullname: Y Shiozawa
– volume: 21
  start-page: 2055
  issue: 9
  year: 2017
  ident: 293_CR9
  publication-title: J Cell Mol Med
  doi: 10.1111/jcmm.13126
  contributor:
    fullname: H Zhao
– volume: 7
  start-page: 2256
  issue: 1
  year: 2017
  ident: 293_CR1
  publication-title: Sci Rep
  doi: 10.1038/s41598-017-02256-4
  contributor:
    fullname: A Deshmukh
– volume: 5
  start-page: 8306
  issue: 18
  year: 2014
  ident: 293_CR6
  publication-title: Oncotarget.
  doi: 10.18632/oncotarget.2059
  contributor:
    fullname: B Corominas-Faja
SSID ssj0000491075
Score 2.285986
Snippet Cancer stem cells obtain energy demand through the activation of glycolysis and lipolysis. It seems that the use of approached targeting glycolysis and...
Abstract Cancer stem cells obtain energy demand through the activation of glycolysis and lipolysis. It seems that the use of approached targeting glycolysis...
SourceID doaj
pubmedcentral
proquest
gale
crossref
pubmed
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
StartPage 30
SubjectTerms Angiogenesis
Cadherins
Cancer
Cell viability
Data processing
EMT
Flow cytometry
Gene expression
Glycolysis
Letter to the Editor
Lipolysis
Mesenchyme
Metabolic pathways
Metabolism
Metastasis
Ovarian cancer stem cells
Stem cells
Transcription
Vimentin
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Li9RAEG5kQfAivh1dpRVBEJpN-pFOjqu4rIIedIW9Nf3KOsuQLJsMMvtD_L1WdWeGCR68eJxUd5h0VVfVl1R_Rcib0ungwPey4HnDpBINs4AjWCh1hPihQxlTgezX6vSH_HyuzvdafWFNWKYHzgt31Hg8fBkddjBAIhMnQ1EEL3wLV4PPqVGp9sDUZc57Adeo6TNmWVdHQ4m8LoCcG1ZAiGM3s0CU-Pr_9sp7YWleMrkXg07ukbtT8kiP85--T27F7gG5ndtJbh6S31_6MHXjon1LV8urPhGOUNsFerHa-OkndiH-ZTcDXXbUo9avKdI5U3yJP9B8FDjQXGrYj1hOlJL1dJttQ5UxqxTmA-hG4Zjqb2nsAp7pWsEUihksuKtH5Ozk49mHUzb1XWBeNXJkTvIggyiC8tJDRuYLp1SsrIp1UygXdekyrT6kNxX4Ay9doWO02gYhYxSPyUHXd_EpoSIIQN-N9h5xjmjAObQ2cK6rNjat9QvybqsDc5XZNUxCJXVlssIMKMygwszNgrxHLe0GIjF2ugDmYiZzMf8ylwV5jTo2SH3RYW3NhV0Pg_n0_Zs5VnWJHVAFX5C306C2B217Ox1VgIdCtqzZyMPZSNibfi7empKZfMNgOEcMKkoJ4lc7Mc7Eercu9mscU8DKwuoWC_IkW97uuQWgTsC5MFvPbHK2MHNJt_yZmMPxK22t-LP_sZLPyR2edpNgXB-Sg_F6HV9Agja6l2kv_gHnBzxm
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: AUTh Library subscriptions: ProQuest Central
  dbid: BENPR
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3di9QwEA_nHYIv4rfVU6IIghC2zUe7fZI7ueMUPOQ84d5CmqR7C0u7brvI3h_i3-tMml2vCD5uMynbzGQ-kpnfEPIuqwpXge5lzvKSSSVKZiCOYC4rPNiPwmU-JMie52c_5JcrdbVHzra1MJhWudWJQVG71uIZ-YRz9NxFJvnEVHgKYPvJx-VPhv2j8J41NtO4Qw54JvHC9uD45Pzbxe68BTxhiHRUvNjMpvmkyxDpBWLpkqVg9NjNyDQFBP9_9fQtQzVOorxllU4fkPvRnaRHA_8fkj3fPCJ3hwaTm8fk99fWxf5ctK3pYr5sAwQJNY2js8XGxp_Yl_iX2XR03lCLcrCiCPBM8Vi_o0NxsKND8mHbY4JRcN_Da7YtVvqByTAfwnAc7ENGLvWNwyqvBUyh6NOCAntCLk9PLj-dsdiJgVlVyp5VkjvpROqUlRZ8NJtWSvncKD8tU1X5IqsGoH1weHLQEFZWaeG9KYwT0nvxlOw3beOfEyqcgHi8LKzFyEeUoC5q4zgv8tqXtbEJ-bDlgV4OeBs6xCnTXA8M08AwjQzTNwk5Ri7tCBEqOzxoVzMdd54uLVbv-gpbYCASTiVdmjorbA1PnTUJeYs81giG0WC2zcysu05__n6hj9Q0w56ogifkfSSqW5Q9E4sX4KMQP2tEeTiihN1qx8NbUdJRW3T6r2wn5M1uGGdiBlzj2zXSpLCysLppQp4Nkrf7bgFxKES-MLsYyeRoYcYjzfw6YInjve1U8Rf__1svyT0e9olgvDgk-_1q7V-BM9ZXr-M--wMcDjhq
  priority: 102
  providerName: ProQuest
– databaseName: Scholars Portal Open Access Journals
  dbid: M48
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3di9QwEA_nieCL-O3qKVEEQaimSfr1IHKKxymcD3oH9xbSJN1bWdpz20X3_hD_XmeSdLniPfi4nUmXZr7byW8IeZnWha3B9ybW8CqRmagSDXVEYtPCQfwobOp8g-zX_PBEfjnNTnfION4qbmB_ZWmH86ROVss3v39u3oPBv_MGX-Zv-xQhW6AorhIG0Su5uEaucykkKvxRzPZ_hGQ4DdC7iMEOpsXS-J3zyrtMIpUH9P_XbV-KW9OeyktB6uA2uRWzS7of1OEO2XHtXXIjzJvc3CN_jjobx3XRrqHLxXnnEUmobi2dLzcm_sQxxb_0pqeLlhpUixVFvGeKb_l7Gs4KWxp6EbsB-418Nu9vM05cGYLMYT1U5UgcfIMuda3FQ19LWEIxxQV_dp8cH3w6_niYxMEMickqOSS15FZawWxmpIGUzbA6y1yuM1dWLKtdkdYBdx_ynxwchpE1K5zThbZCOicekN22a90jQoUVUJ5XhTFYCIkKvEejLedF3riq0WZGXo8yUOcBfkP5sqXMVRCYAoEpFJi6mJEPKKUtIyJn-wvdaq6iIarK4GFeV-NEDATGqaVlzBphGrhqjZ6RFyhjhdgYLTbfzPW679Xn79_UflamOCJV8Bl5FZmaDqRtdDzLAA-FcFoTzr0JJxivmZJHVVKj7ivOsUgVqQTy8y0ZV2JDXOu6NfIw2FnYXTYjD4PmbZ9bQFkKhTCsLiY6OdmYKaVdnHlocfyMW2b88X_87xNyk3tjEQkv9sjusFq7p5CgDfUzb3Z_AUJwOoE
  priority: 102
  providerName: Scholars Portal
Title Modulation of lipolysis and glycolysis pathways in cancer stem cells changed multipotentiality and differentiation capacity toward endothelial lineage
URI https://www.ncbi.nlm.nih.gov/pubmed/30962872
https://www.proquest.com/docview/2211483142/abstract/
https://search.proquest.com/docview/2206223620
https://pubmed.ncbi.nlm.nih.gov/PMC6437852
https://doaj.org/article/9c3995eb05324855b4d00dc3cf95edca
Volume 9
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3da9swEBdtx0Zfxr7nrQvaGAwGbmzJsuzHtrR0g5TSdZA3YUtympHaIXYY6R-yv3d3sh1i9raXQHynEOs-dGff_Y6Qz2EuTQ6-1zeapX4keOpnkEf4JpQWzg9pQusKZK_iy5_R96mY7hHR98K4on2dz4_Lxf1xOb9ztZXLez3u68TG15MzfNmUCDbeJ_uS850U_Vcb8kJKI7o3mGESj-sQIV0gaU79AE43_-GQPOEQukOywAbHkUPt_9c37xxOw8LJnZPo4hl52oWQ9KT9q8_Jni1fkMftUMnNS_JnUpluJhetCrqYLysHO0Kz0tDZYqO7rziL-He2qem8pBplv6II6kzxUX5N24ZgQ9uCw6rBoiIXsruf6ceqNK1gYT2k3khsXBUutaXBzq4FLKEYx4LTekVuL85vzy79bvqCr0UaNX4eMRMZHhihIw1xmQ5yIWycCZukgcitDPMWXB-CnBi8go7yQFqbyczwyFr-mhyUVWnfEsoNhxw8lVpjtsNTcBFFZhiTcWHTItMe-drLQC1bjA3lcpMkVq3sFMhOoezUg0dOUUpbRoTHdheq1Ux1SqJSjR27NsexF4h-k0cmCIzmuoCrRmce-YQyVgiAUWKFzSxb17X69uNGnYgkxDmonHnkS8dUVCBtnXUNC3BTiJk14DwacIKF6iG5VyXVeYhaMYaZKA8jIH_cknElVr2VtlojTwA7C7sbeORNq3nb--4V2CNyoJODjRlSwJwcfnhnPu_-e-V7csicNXGfySNy0KzW9gPEZk0-AoucyhF5dHp-dX0zck844HMSJSNnpX8BWfRAug
link.rule.ids 230,315,733,786,790,870,891,2115,12083,21416,24346,27957,27958,31754,31755,33779,33780,43345,43840,53827,53829
linkProvider National Library of Medicine
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1bi9QwFA66Ivoi3q2uGkUQhLBtkjbtk6ziMqu7-6AjzFtok3QcGNpx2kFmf4i_13PSzLhF8HGakzLNl5xLcvIdQt4klbIV6F5mDS-YTEXBSogjmE2UA_uhbOJ8guxFNvkuP8_SWdhw60Ja5U4nekVtW4N75Eeco-cuEsnfr34yrBqFp6uhhMZ1ckMKITGlT83Ufo8FvF-IbtJwmJnk2VGXILsLxM8Fi8HQscuROfKs_f_q5ivGaZw4ecUSndwld4ILSY8HzO-Ra665T24ORSW3D8jv89aGmly0relysWo97QgtG0vny60JP7EW8a9y29FFQw1iv6ZI6kxxK7-jw4VgS4eEw7bHpCLvsvvX7Mqq9AOw0B9Cb2zsfRYudY3Fm11L6ELRjwWl9ZBMTz5NP05YqL7ATFrInlWSW2lFbFMjDfhlJq7S1GVl6vIiTiunkmog1wcnJwOtYGQVK-dKVVohnROPyEHTNu4JocIKiMELZQxGO6IAFVGXlnOV1a6oSxORdzsM9Grg2NA-NskzPQCmATCNgOnLiHxAlPaCSI_tH7TruQ6rTRcGb-y6CsteIPtNJW0cWyNMDU-tKSPyGjHWSIDRYIbNvNx0nT799lUfp3mCdVAFj8jbIFS3gLYpw4UF-CjkzBpJHo4kYYWacfNuKumgITr9dz5H5NW-GXti1lvj2g3KxDCyMLpxRB4PM2__3QJiT4h2obcazcnRwIxbmsUPzx-OZ7V5yp_-_2-9JLcm0_MzfXZ68eUZuc39mhGMq0Ny0K837jk4Y331wq-4Pzx1Njc
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLZgiGkv3C-BAQYhISGlTexcmscxqDZg0wRDmnixfEspdEnVpELtD-H3co6TVA287THxcSQ7n4_PJx9_h5DXoUqNAt_rG80yP4p55kvgEb4JUwv7R2pC6xJkT5Ojb9HHi_hiq9SXS9rXajooZpeDYvrD5VbOL_WwyxMbnp0c4mHTKGbDucmH18kNWLMs2yLqP5vAF4hN3J5jhqNkWIUo7ALUOfMD2OP89R7Z5RDAA2VgvU3Jaff_76G3tqh--uTWfjS-Tb53I2nSUH4NlrUa6PU_Io9XGuodcquNUulBY3KXXLPFPXKzqVu5uk_-nJSmLftFy5zOpvPSKZtQWRg6ma10-4jljn_LVUWnBdUIrwVF3WiKpwUVbe4cG9rkNJY15i05VuA-01VuqRvsQH9g99hYu0RfaguDl8dm0IViqAx-8QE5H384Pzzy2wIPvo6zqPZVxExkeGBiHWkI_XSg4tgmMrajLIiVTUPV6PdDHJWA49GRClJrZSoNj6zlD8lOURb2MaHccKD5Wao1EiqegRfKpWEsTXKb5VJ75G33g8W8kfEQjv6MEtEAQwAwBAJDrD3yDiGwMUQFbveiXExE-3NEpvFSsFVYWQMFdlRkgsBornN4a7T0yCsEkECNjQKTeCZyWVXi-OsXcRCPQiy1yplH3rRGeQlQ0rK9EwGDQlmunuV-zxKcgO43dzgVrROqBGNIdnkYQfPLTTP2xMS6wpZLtAlgZmF2A488amC9GXe3OjyS9gDfm5h-C8DYSZS3sH1y5Z4vyO7Z-7H4fHz66SnZY27Vcp-l-2SnXiztM4gEa_Xcrfm_rRRg5Q
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Modulation+of+lipolysis+and+glycolysis+pathways+in+cancer+stem+cells+changed+multipotentiality+and+differentiation+capacity+toward+endothelial+lineage&rft.jtitle=Cell+%26+bioscience&rft.au=Pouyafar%2C+Ayda&rft.au=Heydarabad%2C+Milad+Zadi&rft.au=Abdolalizadeh%2C+Jalal&rft.au=Zade%2C+Jalal+Abdolali&rft.date=2019-03-27&rft.issn=2045-3701&rft.eissn=2045-3701&rft.volume=9&rft.spage=30&rft.epage=30&rft_id=info:doi/10.1186%2Fs13578-019-0293-z&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2045-3701&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2045-3701&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2045-3701&client=summon